Key Insights• According to the research report, "Brazil Antiseptic Bathing Products Market Outlook, 2031," published by Actual Market Research, the Brazil Antiseptic Bathing Products Market is expected to reach a market size of more than 1.32 Billion by 2031.• A major clinical breakthrough in Brazilian tertiary hospitals and ICUs is the shift from traditional washbasin bed baths toward single-use soft polyester applicator gloves and pre-moistened Chlorhexidine Digluconate (CHG) cloths. Clinical protocols targeting device-associated nosocomial infections such as Central Line-Associated Bloodstream Infections (CLABSI) and Ventilator-Associated Pneumonia (VAP) have driven this transition to eliminate waterborne contamination from hospital basins.• ANVISA (Agência Nacional de Vigilância Sanitária) enforces strict market authorization under Resolution RDC 907/2024 and Resolution RDC 07/2015. While antiseptic gels and direct pre-operative skin antiseptics require formal pre-market approval, daily antiseptic wash products are closely monitored for microbial efficacy and skin irritation thresholds. Foreign manufacturers must partner with legally constituted Brazilian entities holding Company Operation Authorizations (AFE) to distribute antiseptic lines.• Daily decolonization routines utilizing 2% Chlorhexidine solutions or impregnated wipes have demonstrated significant clinical efficacy in ICU settings. Multi-center clinical evaluations show that daily CHG bathing regimens reduce MDRO acquisition rates by 23% and cut hospital-acquired bloodstream infections by 28% compared to non-antimicrobial wash routines.Market Outlook• High-end private hospital networks (such as Rede D'Or São Luiz, Hospital Albert Einstein, and Hospital Sírio-Libanês) are expanding pre-operative bathing protocols into outpatient and elective surgery programs across secondary cities. Demand is shifting from bulk liquid concentrates toward ready-to-use, microwaveable CHG wipe kits to optimize nursing labor and shorten length-of-stay.• To mitigate severe contact dermatitis and skin dryness caused by frequent chemical bathing in long-term care patients, domestic chemical manufacturers are reformulating cleansing lines.

The market is increasingly adopting non-rinse, pH-balanced antiseptic foams and washcloths enriched with soothing botanical compounds (such as aloe vera and chamomilla) to maintain skin barrier integrity during extended care stay.• Key industry associations include Agência Nacional de Vigilância Sanitária (ANVISA), Associação Brasileira de Profissionais em Controle de Infecção e Epidemiologia Hospitalar (ABIH), and Associação Brasileira da Indústria de Higiene Pessoal, Perfumaria e Cosméticos (ABIHPEC). Whereas key market companies are Rioquímica (Riohex), Laboratórios B. Braun S.A. Brasil, Cremer S.A., Ecolab Brasil, 3M do Brasil, Indústria Farmacêutica Rioquímica, and Mölnlycke Health Care Brasil.Market DynamicsDriver: Stronger national focus on healthcare-associated infection preventionA major driver is Brazil’s strengthening of infection-prevention and antimicrobial-resistance management across healthcare facilities. In February 2026, Agência Nacional de Vigilância Sanitária (Anvisa) approved the PNPCIRAS 2026-2030, establishing national targets, indicators and strategic actions for preventing healthcare-associated infections (HAIs), outbreaks and antimicrobial resistance. This creates a favorable environment for antiseptic bathing products, particularly CHG bathing wipes, antiseptic wipes and waterless cleansing systems that can be incorporated into standardized infection-control protocols. Challenge: Clinical evidence and cost justificationThe main challenge is demonstrating that antiseptic bathing provides measurable clinical and operational value, rather than relying solely on antimicrobial claims.

Hospitals need to consider product safety, skin tolerance, appropriate use and compatibility with existing infection-control protocols. This is particularly important because Brazilian guidance already recommends evidence-based antiseptic practices for specific clinical procedures. For example, Anvisa recommends alcohol-based antiseptics associated with chlorhexidine or iodine for patient skin preparation before surgery.Trend: Shift toward standardized, protocol-driven and waterless cleansingA significant trend is the movement toward standardized patient-hygiene procedures, creating opportunities for ready-to-use CHG cloths, antiseptic wipes, no-rinse cleansers and other waterless formats. These products can reduce preparation requirements and make bedside bathing more consistent between caregivers. The trend is supported by Brazil's broader move toward formalized infection-control programs. Anvisa's 2026-2030 program explicitly emphasizes improving infection-prevention practices at all levels of healthcare, while its 2025 regulatory proposal called for healthcare services to maintain documented infection-prevention actions and protocols.Segment Analysis Brazil Antiseptic Bathing Products Market By Product Type• CHG bath towels and wipes are expected to witness the highest growth within the Brazilian market's product type category.

This growth is driven by the increasing adoption of daily chlorhexidine bathing protocols in Brazilian intensive care units, supported by local clinical evidence. A study conducted at the University Hospital of Universidade Federal de São Paulo demonstrated that daily bathing with a 2% chlorhexidine gluconate (CHG) detergent solution is a feasible, low-cost option for HAI prevention in ICUs, leading to significant reductions in both infection rates and mortality.• Brazilian manufacturers offer diverse antiseptic bathing solutions beyond CHG. A notable example is the Pielsana liquid antiseptic soap with PHMB (Polyhexamethylene Biguanide), which is marketed for both hospital and home use. This product is specifically indicated for bed baths (banho no leito) and does not require rinsing, making it practical for immobile patients. The formulation, registered with ANVISA, offers bactericidal, fungicidal, and virucidal action with low skin toxicity highlighting a local focus on patient comfort alongside efficacy.• 4% CHG degerming solutions, such as Riohex manufactured by Rioquímica, are widely used in Brazilian hospitals for preoperative patient bathing, surgical site antisepsis, and hand hygiene of healthcare professionals. The product's label explicitly indicates its use for full-body hygiene before surgical intervention and for disinfection after contact with multidrug-resistant pathogens.

This establishes CHG solutions as a cornerstone product in Brazilian infection prevention protocols.• Antiseptic wipes in Brazil sit at the intersection of the broader disinfectant wipes market. The market for disinfectant wipes is influenced by ongoing awareness of hygiene due to infectious diseases and is also shaped by retail distribution channels, including supermarkets and pharmacies. However, manufacturers face challenges including price volatility of raw materials and intense competition.• Antiseptic shampoo caps are identified as a distinct segment in the Brazilian market. While specific details about local product formulations are limited, this niche is expected to grow alongside demand for specialized infection prevention products in ICUs and long-term care settings.• Others category include various versions. A unique product type available in Brazil is the antiseptic liquid soap with PHMB, which serves as an alternative to CHG-based products. The formulation is designed to be gentle on sensitive skin, making it suitable for daily use in both domestic and hospital environments Brazil Antiseptic Bathing Products Market By Application• ICUs represent the largest and most critical application segment for antiseptic bathing products in Brazil.

The clinical urgency is underscored by data from a 2019 point-prevalence study across 15 Brazilian hospitals, which found that 26.4% of ICU patients had a suspected or confirmed healthcare-associated infection, with 76.5% having at least one infection acquired in the unit. Pneumonia (50.0%) and bloodstream infections (34.5%) were the most prevalent. Notably, the prevalence of HAIs in Brazilian public hospitals was extremely high at 82.5% in adult clinical-surgical ICUs.• Surgical wards represent another significant application segment. Brazilian hospital protocols recommend preoperative bathing with 4% CHG solution or CHG wipes to reduce surgical site infections. Products like Riohex 4% are explicitly labeled for preoperative patient hygiene, indicating established protocols in major hospitals.• Medical wards also contribute to market demand. The use of antiseptic bathing products in general medical wards is driven by the high overall burden of HAIs, with cancer identified as an independent risk factor for developing infections.• The home healthcare segment in Brazil is growing, supported by products like the Pielsana PHMB liquid antiseptic, which is indicated for bed bath hygiene in home settings.

The availability of ANVISA-registered antiseptics for non-hospital use suggests an expanding consumer base, including caregivers and family members managing hygiene for immobile patients at home.• Dialysis services present a unique application area. A study at a tertiary hospital in São Paulo (2023-2025) found that 18.3% of dialysis patients required hospitalization due to HD-associated HAIs, with temporary vascular access showing the highest infection rates (76.6% of infections). The most frequent pathogen was Staphylococcus aureus (55.17%), with 25% being oxacillin-resistant. This drives demand for antiseptic bathing products in outpatient dialysis settings.Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Antiseptic Bathing Products Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• CHG Bath Towels & Wipes• Antiseptic Bathing Solutions• CHG Solutions• Antiseptic Wipes• Antiseptic Shampoo Caps• Other ProductsBy Application• Surgical Wards• Intensive Care Unit (ICU)• Medical Wards• Home Healthcare / Long-Term Care• Other Applications.